Stanley Druckenmiller Cabaletta Bio, Inc. Transaction History
Duquesne Family Office LLC
- $4.39 Billion
- Q1 2024
A detailed history of Stanley Druckenmiller (Duquesne Family Office LLC) transactions in Cabaletta Bio, Inc. stock. As of the latest transaction made, Duquesne Family Office LLC holds 417,000 shares of CABA stock, worth $4.25 Million. This represents 0.16% of its overall portfolio holdings.
Number of Shares
417,000Holding current value
$4.25 Million% of portfolio
0.16%Shares
1 transactions
Others Institutions Holding CABA
# of Institutions
168Shares Held
48.8MCall Options Held
300KPut Options Held
1.31M-
Black Rock Inc. New York, NY4.06MShares$41.3 Million0.0% of portfolio
-
State Street Corp Boston, MA3.74MShares$38.1 Million0.0% of portfolio
-
Jennison Associates LLC3.42MShares$34.9 Million0.04% of portfolio
-
Fred Alger Management, LLC New York, NY3.11MShares$31.7 Million0.27% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.04MShares$30.9 Million0.1% of portfolio
About Cabaletta Bio, Inc.
- Ticker CABA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,014,000
- Market Cap $296M
- Description
- Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...